Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
Buy Reports For This Company

Accentia Biopharmaceuticals, Inc.
TampaFL United States
 

btn-overview-2btn-people-1btn-competition-1btn-financials-1

Company Description

Accentia Biopharmaceuticals is accentuating its positives and eliminating its negatives. The drug development company is focused on two development-stage drugs, multiple sclerosis drug Revimmune and BiovaxID, a possible vaccine for non-Hodgkin's lymphoma being developed by majority-owned subsidiary BioVest International. BioVest also sells cell growth instruments and offers contract manufacturing of cell cultures. The company and its subsidiaries (including BioVest) filed for Chapter 11 bankruptcy protection in late 2008 and emerged in late 2010.

324 S. Hyde Park Ave., Ste. 350Phone: 813-864-2554http://www.accentia.net
TampaFL 33606Fax: 813-258-6912Map Map This Company
United States

Try a Full Premium Subscription

Access over 85 million companies
Call (866) 443-3939 or

btn-free-trial

Prepare for your Sales call

Try a Small Business Subscription
Starting $89 per month

btn-subscribe-now

Accentia Biopharmaceuticals, Inc. Rankings

Executives

16 executives listed for Accentia Biopharmaceuticals, Inc.'s Tampa, FL location.
Chairman and CEOFrancis O'DonnellE-mail
President and General CounselSamuel DuffeyE-mail
Acting CFO and ControllerGarrisonHasaraE-mail

More Accentia Biopharmaceuticals, Inc. Executives

Financials

Company TypePublicHeadquarters
Fiscal Year-EndSeptember
2011 Employees68
More Accentia Biopharmaceuticals, Inc. Financials
D&B logoDNBi

Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Accentia Biopharmaceuticals, Inc. now.

  • Reduce risk.
  • Drive greater profitability.
  • Increase cash flow.
Get a Credit Report Now

Sponsored Links